In 2003, a strong rebound in medical device M&A
After dropping markedly for two consecutive years, both the number of acquisitions in medical devices and the total dollar volume of those deals jumped significantly in 2003, according to information from Windhover Information's Strategic Transactions Database of industry transactions.
You may also be interested in...
After dropping markedly for two consecutive years, both the number of acquisitions in medical devices and the total dollar volume of those deals jumped significantly in 2003, reaching 71 and $9.17 billion, respectively. And if the dollar volumes and number of deals in 2003 weren't good news enough, an analysis of some of the trends behind the deal-making should give device executives even more cause to be happy. Thus, while a significant number of the total deals do fall within only two clinical categories, cardiovascular and orthopedics, the larger picture shows an M&A climate that is quite diversified. Similarly, the perception that deal-making is concentrated in the hands of a small group of large companies isn't borne out by the data. That said, new technology trends, most notably the convergence of drugs and devices, and new deal structures suggest, at least anecdotally, that device M&A may be changing.
Gilead ups its investment in its TIGIT partner, as the firms pivot to a less crowded market opportunity in upper GI cancers.
While an EU-level project is underway to address delays to drug trials that are conducted in combination with IVD performance studies, Denmark has streamlined its processes to address the issue at the national level.